Saffari A

Title : Childhood-onset hereditary spastic paraplegia and its treatable mimics - Ebrahimi-Fakhari_2022_Mol.Genet.Metab_137_436

Author(s) : Ebrahimi-Fakhari D , Saffari A , Pearl PL

Ref : Mol Genet Metab , 137 :436 , 2022

Abstract :

PubMedSearch : Ebrahimi-Fakhari_2022_Mol.Genet.Metab_137_436

PubMedID: 34183250

Title : Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study - Saffari_2019_Orphanet.J.Rare.Dis_14_96

Author(s) : Saffari A , Brosse I , Wiemer-Kruel A , Wilken B , Kreuzaler P , Hahn A , Bernhard MK , van Tilburg CM , Hoffmann GF , Gorenflo M , Hethey S , Kaiser O , Kolker S , Wagner R , Witt O , Merkenschlager A , Mockel A , Roser T , Schlump JU , Serfling A , Spiegler J , Milde T , Ziegler A , Syrbe S

Ref : Orphanet J Rare Dis , 14 :96 , 2019

Abstract :

PubMedSearch : Saffari_2019_Orphanet.J.Rare.Dis_14_96

PubMedID: 31053163

Saffari A

References (2)

1. Childhood-onset hereditary spastic paraplegia and its treatable mimics - Ebrahimi-Fakhari_2022_Mol.Genet.Metab_137_436

2. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study - Saffari_2019_Orphanet.J.Rare.Dis_14_96